Biogen Inc. buy StockNews.com
Start price
28.12.24
/
50%
€146.05
Target price
28.12.25
-
Performance (%)
-16.12%
Price
17.10.25
€122.50
Summary
This prediction is currently active. The prediction for Biogen Inc. disappoints with a performance of -16.12%. This prediction currently runs until 28.12.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -2.970% | -2.970% |
| iShares Core DAX® | -1.072% | 2.415% |
| iShares Nasdaq 100 | 1.923% | 3.851% |
| iShares Nikkei 225® | 4.414% | 6.958% |
| iShares S&P 500 | 1.247% | 2.390% |
Comments by StockNews_com for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for BIIB provided by MarketBeat